Cor Vasa 2006, 48(7-8):262-266 | DOI: 10.33678/cor.2006.083

Plasma levels of thiocyanate in the Czech population and their genetic determination

Jaroslav A. Hubáček1,4,*, Jan Piťha2, Zdena Škodová3, Věra Lánská4, Rudolf Poledne1,4
1 Pracoviště experimentální medicíny, Laboratoř molekulární genetiky
2 Pracoviště preventivní kardiologie
3 Statistické oddělení, Institut klinické a experimentální medicíny
4 Centrum pro výzkum chorob srdce a cév, Praha, Česká republika

Background:
Plasma thiocyanate levels are a commonly used marker for smoking status determination. It is not known whether there is any genetic predisposition in terms of plasma thiocyanate levels. We have evaluated possible genetic predetermination of plasma thiocyanate levels in a population-based study.


Material/methods:
In 131 men and 154 women, the plasma levels of thiocyanate were detected photometrically after reaction with Fe(NO3)3. Twenty-three genetic markers on 8 chromosomes were analyzed by PCR.

Results:
The plasma levels of thiocyanate were significantly (p < 0.01) higher in smokers compared to non-smokers and in males (p < 0.01) compared to females.
The effects of genetic markers at positions 11q23 (p < 0.05) and 19q13.1 (p < 0.01) on plasma thiocyanate levels were determined in both males and females in independent analyses. Other variants exhibited no significant effect on the plasma levels of thiocyanate.

Conclusion:
The plasma levels of thiocyanate are higher in males than in females and in smokers than in non-smokers. Out of the 23 analyzed genetic variants, two are associated with plasma levels of thiocyanate. The plasma levels of thiocyanate are not likely to be a genetically independent marker for smoking/non-smoking status.

Keywords: Smoking; Polymorphisms; Thiocyanate

Published: July 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hubáček JA, Piťha J, Škodová Z, Lánská V, Poledne R. Plasma levels of thiocyanate in the Czech population and their genetic determination. Cor Vasa. 2006;48(7-8):262-266. doi: 10.33678/cor.2006.083.
Download citation

References

  1. Molarius A, Parsons RW, Dobson AJ, et al. Trends in cigarette smoking in 36 populations from the early 1980s to the mid-1990s: findings from the WHO MONICA Project. Am J Public Health 2001;91:206-12. Go to original source... Go to PubMed...
  2. Borges D, Junge B. Thiocyanate as an indicator of tobacco smoking. Preventive Medicine 1979;3:351-7. Go to original source... Go to PubMed...
  3. Multinational monitoring of trends and determinants in cardiovascular diseases: "MONICA Project". Manual of operations WHO/MNC 82.2, Nov 1983.
  4. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extraction DNA from human nucleated cells. Nucl Acids Res 1988;16:1215. Go to original source... Go to PubMed...
  5. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-48. Go to original source...
  6. Waterworth DM, Hubacek JA, Kovar J, et al. The plasma levels of remnant particles are determined in part by variation in the apoCIII gene insulin response element and the apoCI-apoE cluster. J Lipid Res 2000; 41:1103-9. Go to original source...
  7. Boerwinkle E, Chan L. A three codon insertion/deletion polymorphism in the signal peptide region of the human apolipoprotein B (apo B) gene directly typed by the polymerase chain reaction. Nucl Acids Res 1990;17:4003. Go to original source... Go to PubMed...
  8. Hubacek JA, Lacha J. Alternative method for diagnosis of two polymorphisms in the human transforming growth factor-β1 by PCR-mediated double site-directed mutagenesis. Clin Chim Acta 2000;295:187-91. Go to original source... Go to PubMed...
  9. Hubacek JA, Waterworth DM, Pitha J, et al. Polymorphisms in the lipoprotein lipase and hepatic lipase genes and plasma lipid values in Czech population. Physiol Res 2000;50:345-51.
  10. Hubacek JA, Stueber F, Froehlich D, et al. Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients - gender-specific genetic predisposition to sepsis. Crit Care Med 2001;29:557-61. Go to original source... Go to PubMed...
  11. Hubacek JA, Berge KE, Štefková J, et al. Polymorphisms in ABCG5 and ABCG8 transporters and plasma cholesterol levels. Physiol Res 2004;53:395-401. Go to original source...
  12. Wang J, Freeman DJ, Grundy SM, et al. Linkage between cholesterol 7a-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. J Clin Invest 1998;101:1283-91. Go to original source... Go to PubMed...
  13. Hubacek JA, Rothe G, Pitha J, et al. C(-260) → T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999;99:3218-20. Go to original source... Go to PubMed...
  14. Rigat B, Hubert C, Corvol P, Subrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucl Acids Res 1993;20:1433. Go to original source... Go to PubMed...
  15. Yoshida H, Kuriyama S, Atsumi Y, et al. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996;50: 657-64. Go to original source... Go to PubMed...
  16. Day IN, Humphries SE. Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Anal Biochem 1994;222:389-95. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.